nonsteroidal weak estrogen group never major metabolite selective estrogen receptor modulator serm zindoxifene high affinity estrogen receptor er inhibits growth erpositive breast cancer cells however contradictorily subsequent research found drug produced fully estrogenic effects vitro similarly less actively estradiol antiestrogenic activity reason discrepancy findings unclear though may due unexpected estrogenic activity may responsible failure zindoxifene clinical trials treatment breast drug article relating genitourinary system stub help wikipedia expanding